Bull vs Bear: GlaxoSmithKline
Investors' Chronicle - A podcast by Investors' Chronicle - Venerdì
Categorie:
GlaxoSmithKline (GSK) is a company that divides opinion and therefore an ideal candidate for the IC's Bull vs Bear series. In this episode, Simon Gergel from the Merchants Trust argues the bull case against the ICs pharma specialist (and GSK sceptic), Megan Boxall. Hosted on Acast. See acast.com/privacy for more information.
